GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (OTCPK:ENDPQ) » Definitions » Cyclically Adjusted PB Ratio

Endo International (Endo International) Cyclically Adjusted PB Ratio : 0.00 (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Endo International Cyclically Adjusted PB Ratio?

As of today (2024-05-17), Endo International's current share price is $0.0006. Endo International's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $4.04. Endo International's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Endo International's Cyclically Adjusted PB Ratio or its related term are showing as below:

During the past years, Endo International's highest Cyclically Adjusted PB Ratio was 7.94. The lowest was 0.01. And the median was 0.67.

ENDPQ's Cyclically Adjusted PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.88
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Endo International's adjusted book value per share data for the three months ended in Dec. 2023 was $-28.048. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.04 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Endo International Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Endo International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Cyclically Adjusted PB Ratio Chart

Endo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.67 0.41 0.01 -

Endo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - - -

Competitive Comparison of Endo International's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo International's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Endo International's Cyclically Adjusted PB Ratio falls into.



Endo International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Endo International's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0006/4.04
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endo International's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Endo International's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-28.048/120.7486*120.7486
=-28.048

Current CPI (Dec. 2023) = 120.7486.

Endo International Quarterly Data

Book Value per Share CPI Adj_Book
201403 19.496 100.573 23.407
201406 18.396 100.773 22.043
201409 16.208 100.474 19.479
201412 15.429 99.576 18.710
201503 23.177 99.975 27.993
201506 29.545 100.573 35.472
201509 28.249 100.274 34.017
201512 26.868 99.676 32.548
201603 26.607 99.676 32.232
201606 28.108 101.072 33.580
201609 27.151 100.274 32.695
201612 12.117 99.676 14.679
201703 9.807 100.374 11.798
201706 3.624 100.673 4.347
201709 3.426 100.474 4.117
201712 2.171 100.075 2.619
201803 -0.032 100.573 -0.038
201806 -0.277 101.072 -0.331
201809 -0.978 101.371 -1.165
201812 -2.221 100.773 -2.661
201903 -2.199 101.670 -2.612
201906 -2.608 102.168 -3.082
201909 -2.917 102.268 -3.444
201912 -3.821 102.068 -4.520
202003 -3.230 102.367 -3.810
202006 -3.111 101.769 -3.691
202009 -3.398 101.072 -4.060
202012 -2.813 101.072 -3.361
202103 -2.588 102.367 -3.053
202106 -2.643 103.364 -3.088
202109 -2.954 104.859 -3.402
202112 -5.323 106.653 -6.026
202203 -5.576 109.245 -6.163
202206 -13.601 112.779 -14.562
202209 -16.688 113.504 -17.753
202212 -17.696 115.436 -18.510
202303 -17.658 117.609 -18.129
202306 -17.546 119.662 -17.705
202309 -17.682 120.749 -17.682
202312 -28.048 120.749 -28.048

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Endo International  (OTCPK:ENDPQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Endo International Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Endo International's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo International (Endo International) Business Description

Traded in Other Exchanges
Address
Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.
Executives
James Patrick Tursi officer: Executive VP, Global R&D 106 ASHLEY COURT, MOORESTOWN NJ 08057
Frank B. Raciti officer: VP, Controller and CAO C/O ENDO HEALTH SOLUTIONS INC., 1400 ATWATER DRIVE, MALVERN PA 19355
Shane Cooke director TREASURY BUILDING LOWER GRAND CANAL ST., DUBLIN 2 L2 00000
William P Montague director
Jennifer M Chao director 7 PURITAN WOODS ROAD, RYE NY 10580
George Apostol officer: EVP, Head of Global R&D C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN 4 L2 00000
Mary Christine Smith director 3658 50TH AVE NE, SEATTLE WA 98105
Mark T. Bradley officer: EVP, Chief Financial Officer C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000
Mark G Barberio director 19 WIK STREET, WILLIAMSVILLE NY 14221
Jack D. Boyle officer: SVP, Interim Controller C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000
Roger H Kimmel director LATHAM & WATKINS, 885 THIRD AVENUE, NEW YORK NY 10022
Domenico Ciarico officer: EVP & Chief Commercial Officer C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000
Rahul Garella officer: EVP, Intl Pharmaceuticals C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000
Nancy J Hutson director 64 MONTAUK AVENUE, STONINGTON CT 06378
Carrie Ann Nichol officer: VP, Controller & CAO 927 GRANDVIEW DRIVE, EXTON PA 19341